Logo image of 1BAYN.MI

BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis

BIT:1BAYN - Euronext Milan - DE000BAY0017 - Common Stock - Currency: EUR

24.045  +1 (+4.34%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to 1BAYN. 1BAYN was compared to 50 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of 1BAYN have multiple concerns. 1BAYN is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

1BAYN had positive earnings in the past year.
1BAYN had a positive operating cash flow in the past year.
In multiple years 1BAYN reported negative net income over the last 5 years.
Each year in the past 5 years 1BAYN had a positive operating cash flow.
1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

1BAYN's Return On Assets of -2.30% is on the low side compared to the rest of the industry. 1BAYN is outperformed by 66.00% of its industry peers.
The Return On Equity of 1BAYN (-8.00%) is worse than 66.00% of its industry peers.
Industry RankSector Rank
ROA -2.3%
ROE -8%
ROIC N/A
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1BAYN.MI Yearly ROA, ROE, ROIC1BAYN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

In the last couple of years the Operating Margin of 1BAYN has declined.
With a Gross Margin value of 54.36%, 1BAYN is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
1BAYN's Gross Margin has declined in the last couple of years.
1BAYN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.36%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
1BAYN.MI Yearly Profit, Operating, Gross Margins1BAYN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

1BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 1BAYN has about the same amount of shares outstanding.
Compared to 5 years ago, 1BAYN has about the same amount of shares outstanding.
1BAYN has a better debt/assets ratio than last year.
1BAYN.MI Yearly Shares Outstanding1BAYN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1BAYN.MI Yearly Total Debt VS Total Assets1BAYN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

Based on the Altman-Z score of 0.80, we must say that 1BAYN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.80, 1BAYN is doing worse than 62.00% of the companies in the same industry.
The Debt to FCF ratio of 1BAYN is 8.90, which is on the high side as it means it would take 1BAYN, 8.90 years of fcf income to pay off all of its debts.
1BAYN has a Debt to FCF ratio (8.90) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.11 is on the high side and indicates that 1BAYN has dependencies on debt financing.
The Debt to Equity ratio of 1BAYN (1.11) is worse than 64.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 8.9
Altman-Z 0.8
ROIC/WACCN/A
WACC6.18%
1BAYN.MI Yearly LT Debt VS Equity VS FCF1BAYN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

1BAYN has a Current Ratio of 1.19. This is a normal value and indicates that 1BAYN is financially healthy and should not expect problems in meeting its short term obligations.
1BAYN has a worse Current ratio (1.19) than 72.00% of its industry peers.
1BAYN has a Quick Ratio of 1.19. This is a bad value and indicates that 1BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
1BAYN has a Quick ratio of 0.72. This is amonst the worse of the industry: 1BAYN underperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.72
1BAYN.MI Yearly Current Assets VS Current Liabilites1BAYN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

3

3. Growth

3.1 Past

1BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.09%.
Measured over the past years, 1BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.27% on average per year.
1BAYN shows a decrease in Revenue. In the last year, the revenue decreased by -2.16%.
The Revenue has been growing slightly by 1.37% on average over the past years.
EPS 1Y (TTM)-21.09%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-43.24%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-1.12%

3.2 Future

The Earnings Per Share is expected to grow by 1.19% on average over the next years.
Based on estimates for the next years, 1BAYN will show a small growth in Revenue. The Revenue will grow by 1.18% on average per year.
EPS Next Y-8.65%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
EPS Next 5Y1.19%
Revenue Next Year0.26%
Revenue Next 2Y0.88%
Revenue Next 3Y1.21%
Revenue Next 5Y1.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1BAYN.MI Yearly Revenue VS Estimates1BAYN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
1BAYN.MI Yearly EPS VS Estimates1BAYN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.76, the valuation of 1BAYN can be described as very cheap.
94.00% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 24.29, 1BAYN is valued rather cheaply.
With a Price/Forward Earnings ratio of 5.21, the valuation of 1BAYN can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1BAYN indicates a rather cheap valuation: 1BAYN is cheaper than 96.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.42. 1BAYN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.76
Fwd PE 5.21
1BAYN.MI Price Earnings VS Forward Price Earnings1BAYN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1BAYN indicates a rather cheap valuation: 1BAYN is cheaper than 90.00% of the companies listed in the same industry.
96.00% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.15
EV/EBITDA 6.17
1BAYN.MI Per share data1BAYN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.15%
EPS Next 3Y1.51%

More info and screens

0

5. Dividend

5.1 Amount

1BAYN has a yearly dividend return of 0.48%, which is pretty low.
1BAYN's Dividend Yield is slightly below the industry average, which is at 3.06.
With a Dividend Yield of 0.48, 1BAYN pays less dividend than the S&P500 average, which is at 2.43.
Industry RankSector Rank
Dividend Yield 0.48%

5.2 History

The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-5.13%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
1BAYN.MI Yearly Income VS Free CF VS Dividend1BAYN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

More info and screens

BAYER AG-REG

BIT:1BAYN (5/6/2025, 7:00:00 PM)

24.045

+1 (+4.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-05 2025-03-05/bmo
Earnings (Next)05-13 2025-05-13
Inst Owners47.61%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.62B
Analysts67.59
Price Target27.58 (14.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.48%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-5.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.93%
Min EPS beat(2)-17.26%
Max EPS beat(2)3.41%
EPS beat(4)3
Avg EPS beat(4)0.78%
Min EPS beat(4)-17.26%
Max EPS beat(4)12.55%
EPS beat(8)5
Avg EPS beat(8)-3.08%
EPS beat(12)8
Avg EPS beat(12)-0.96%
EPS beat(16)12
Avg EPS beat(16)2.1%
Revenue beat(2)1
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-3.42%
Max Revenue beat(2)1.79%
Revenue beat(4)2
Avg Revenue beat(4)-1.4%
Min Revenue beat(4)-4%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-2.97%
Revenue beat(12)5
Avg Revenue beat(12)-1.57%
Revenue beat(16)9
Avg Revenue beat(16)-0.6%
PT rev (1m)-1.72%
PT rev (3m)-1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.84%
EPS NY rev (1m)-0.27%
EPS NY rev (3m)-2.26%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)-3.24%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.19%
Valuation
Industry RankSector Rank
PE 4.76
Fwd PE 5.21
P/S 0.51
P/FCF 5.15
P/OCF 3.21
P/B 0.74
P/tB N/A
EV/EBITDA 6.17
EPS(TTM)5.05
EY21%
EPS(NY)4.61
Fwd EY19.19%
FCF(TTM)4.67
FCFY19.42%
OCF(TTM)7.5
OCFY31.18%
SpS47.44
BVpS32.48
TBVpS-20.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.3%
ROE -8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.36%
FCFM 9.84%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 8.9
Debt/EBITDA 4.07
Cap/Depr 31.63%
Cap/Sales 5.96%
Interest Coverage N/A
Cash Conversion 84.55%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.72
Altman-Z 0.8
F-Score6
WACC6.18%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.09%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-43.24%
EPS Next Y-8.65%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
EPS Next 5Y1.19%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-1.12%
Revenue Next Year0.26%
Revenue Next 2Y0.88%
Revenue Next 3Y1.21%
Revenue Next 5Y1.18%
EBIT growth 1Y-111.6%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year66.19%
EBIT Next 3Y20.82%
EBIT Next 5Y9.38%
FCF growth 1Y93.91%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y43.95%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%